Dr Inbar Nardi Agmon is undertaking a two-year clinical fellowship at Toronto General Hospital, Ontario, CA.
Following the completion of her subspecialty in cardiology and until July 2023, she served as the head of the cardio-oncology clinic at Beilinson Hospital, Rabin Medical Center, Israel.
In addition to her clinical responsibilities and participation in clinical studies both in Israel and Toronto, Dr Nardi Agmon operates a basic-science laboratory in Israel, where she investigates the effects of immune checkpoint inhibitors on atherosclerosis.
